A detailed history of Mml Investors Services, LLC transactions in Intra Cellular Therapies, Inc. stock. As of the latest transaction made, Mml Investors Services, LLC holds 3,997 shares of ITCI stock, worth $504,661. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,997
Previous 4,130 3.22%
Holding current value
$504,661
Previous $283,000 3.18%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024

SELL
$67.99 - $80.84 $9,042 - $10,751
-133 Reduced 3.22%
3,997 $292,000
Q2 2024

Aug 14, 2024

SELL
$64.76 - $79.84 $356,115 - $439,040
-5,499 Reduced 57.11%
4,130 $283,000
Q1 2024

May 14, 2024

BUY
$64.37 - $75.65 $149,402 - $175,583
2,321 Added 31.76%
9,629 $666,000
Q4 2023

Feb 14, 2024

SELL
$46.37 - $73.65 $89,818 - $142,660
-1,937 Reduced 20.95%
7,308 $523,000
Q3 2023

Nov 14, 2023

BUY
$52.09 - $64.1 $291,860 - $359,152
5,603 Added 153.84%
9,245 $482,000
Q2 2023

Aug 14, 2023

SELL
$54.67 - $66.44 $61,066 - $74,213
-1,117 Reduced 23.47%
3,642 $231,000
Q1 2023

May 12, 2023

BUY
$43.8 - $56.99 $36,485 - $47,472
833 Added 21.22%
4,759 $258,000
Q4 2022

Feb 13, 2023

BUY
$44.07 - $54.45 $173,018 - $213,770
3,926 New
3,926 $208,000
Q1 2021

May 14, 2021

SELL
$30.8 - $39.51 $294,756 - $378,110
-9,570 Closed
0 $0
Q4 2020

Feb 12, 2021

BUY
$23.34 - $32.22 $223,363 - $308,345
9,570 New
9,570 $304,000
Q3 2020

Nov 13, 2020

SELL
$17.61 - $31.86 $549,432 - $994,032
-31,200 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$14.35 - $26.64 $447,720 - $831,168
31,200 New
31,200 $800,000

Others Institutions Holding ITCI

About Intra-Cellular Therapies, Inc.


  • Ticker ITCI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 94,401,696
  • Market Cap $11.9B
  • Description
  • Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...
More about ITCI
Track This Portfolio

Track Mml Investors Services, LLC Portfolio

Follow Mml Investors Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mml Investors Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mml Investors Services, LLC with notifications on news.